designsynthesisantitumorevaluationsandmolecularmodelingstudiesofnovel35substitutedindolin2onederivatives
文献类型:期刊论文
作者 | Luo Xiaomin![]() ![]() ![]() ![]() ![]() ![]() |
刊名 | actapharmacologicasinica
![]() |
出版日期 | 2007 |
卷号 | 28期号:1页码:140 |
关键词 | Protein-tyrosine kinase Indolin-2-one Antitumor drug screening assays Drug design Molecular models |
ISSN号 | 1671-4083 |
英文摘要 | Aim: To design and synthesize a novel class of antitumor agents, featuring the 3,5-substituted indolin-2-one framework. Methods: Based on enzyme binding features of (Z)-SU5402, introducing a b-pyrrole group at the 3-position of the indolin-2-one core, a series of novel 3,5-substituted indolin-2-ones were designed and synthesized. Four human carcinoma cell lines of A-431, A-549, MDA-MB-468, and Autosomal Dominant Polycystic Kidney disease were chosen for the cell proliferation assay. Results: Twenty new compounds (1a_t) with E configuration have been designed, synthesized and bioassayed. Their structural features were determined by nuclear magnetic resonance (NMR) spectra, low- and high-resolution mass spectra, and confirmed by X-ray crystallography. Although the enzyme assay showed a weak inhibition effect against the epidermal growth factor receptor, vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet-derived growth factor receptor tyrosine kinases, the cell-based antitumor activity was promising. Compounds 1g and 1h showed higher inhibitory activity toward the A-549 and MDA-MB-468 cell lines with IC_(50)of 0.065_9.4 μmol/L. Conclusion: This study provides a new template for further development of potent antitumor drugs. |
语种 | 英语 |
源URL | [http://119.78.100.183/handle/2S10ELR8/287368] ![]() |
专题 | 中国科学院上海药物研究所 |
作者单位 | 中国科学院上海药物研究所 |
推荐引用方式 GB/T 7714 | Luo Xiaomin,Shen Xu,Lin Liping,et al. designsynthesisantitumorevaluationsandmolecularmodelingstudiesofnovel35substitutedindolin2onederivatives[J]. actapharmacologicasinica,2007,28(1):140. |
APA | Luo Xiaomin.,Shen Xu.,Lin Liping.,Chen Kaixian.,Li Haihong.,...&Jiang Hualiang.(2007).designsynthesisantitumorevaluationsandmolecularmodelingstudiesofnovel35substitutedindolin2onederivatives.actapharmacologicasinica,28(1),140. |
MLA | Luo Xiaomin,et al."designsynthesisantitumorevaluationsandmolecularmodelingstudiesofnovel35substitutedindolin2onederivatives".actapharmacologicasinica 28.1(2007):140. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。